ENTtoday

Botulinum Toxin Injections for ADSD and Chronic Salivary Aspiration

by Arevalo, Jennifer Decker MA •

We hope to investigate this treatment prospectively and determine whether patients who do not respond well to treatment may do so with a higher dosage, said Dr. Raval.

References

  1. Lange DJ. Systemic effects of botulinum toxin. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, 1994:109-18.

    [Context Link]

  2. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope; 2001;111(2):218-26.

    [Context Link]

  3. Rohrbach S, Laskawi R. Botulinum in ENT medicine. Laryngorhinootologie 2003;82(3);202-13.

    [Context Link]

  4. Yin S, Stucker FJ, Nathan CO. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review). J La State Med Soc 2001;153(2):92-7.

    [Context Link]

  5. Holden PK, Vokes DE, Taylor MB, Till JA, Crumley RL. Long-term botulinum toxin dose consistency for the treatment of adductor spasmodic dysphonia. Abstract presented at the Combined Otolaryngology Spring Meeting (COSM), April 26, 2007.

    [Context Link]

  6. Id. [Context Link]
  7. Id. [Context Link]
  8. Paniello RC, Barlow J, Serna JS. Longitudinal follow-up of adductor spasmodic dysphonia patients following botulinum toxin injection: quality of life results. Abstract presented at the Combined Otolaryngology Spring Meeting (COSM), April 29, 2007.

    [Context Link]

  9. Id. [Context Link]
  10. Raval TH, Elliott, CA. Salivary aspiration: a role for botulinum toxin treatment to the salivary glands. Abstract presented at the Combined Otolaryngology Spring Meeting (COSM), April 26, 2007.

    [Context Link]

©2007 The Triological Society